About Klenzaids
Klenzaids is a Healthcare company based in Mumbai (India) founded in 1978. It operates as a manufacture of Aseptic, Bioclean, and Containment equipment, along with design of turnkey facilities for healthcare and related sectors. The company has 382 employees. Its Indian entity Klenzaids Contamination Controls Private Limited reported revenue of ₹194 Cr. Klenzaids offers products and services including Aseptic Equipment and Design and Build Services. Its focus areas include Pharmaceuticals, Drug Manufacturing, Aseptic Processing and Life Sciences.
Company details
Klenzaids is known for manufacturing Aseptic, Bioclean, and Containment equipment that are essential for plants in pharmaceutical, biological, life science, healthcare, electrical, space, and defense industries. Design and build services for turnkey labs and facilities are also provided to universities and public health establishments. As a joint venture member of Syntegon Technologies, a commitment to combating climate change is maintained. Contamination control practices have been refined over half a century through collaborations with various sectors to ensure products and environments are kept free from unintended elements, supporting global manufacturing norms across boundaries.
- Headquarters Mumbai, India
- Employees 382
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Social LinkedIn X Facebook YouTube
- Legal Name Klenzaids Contamination Controls Pvt. Ltd
- Date of Incorporation 01 Feb, 1978
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue₹194 Cr
FY 2025 · +13% YoY
- Net Profit₹22.14 Cr
FY 2025 · 11% margin
- EBITDA₹32.43 Cr
FY 2025 · 17% margin
- Employee Count382
Associated legal entities of Klenzaids
Klenzaids operates through Klenzaids Contamination Controls Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Klenzaids Contamination Controls Private Limited CIN U33112MH1978PTC020112 | Active | 01 Feb 1978 | Mumbai, Maharashtra | ₹194 Cr | 382 | 6 | View details |
Products & Services of Klenzaids
Klenzaids offers a comprehensive portfolio of products and services, including Aseptic Equipment and Design and Build Services.
Aseptic equipment is manufactured for pharmaceutical processes to maintain controlled environments.
Design and build services are provided for turnkey facilities in various industries to ensure high standards of contamination control.
Apps and channels of Klenzaids
its YouTube channel Klenzaids Contamination.Controlled. has 16.7K subscribers and 16 videos.
Videos from Klenzaids
The most watched videos on Klenzaids's YouTube channel, Klenzaids Contamination.Controlled. (16.7K subscribers). Click a video to play it here.
More on Klenzaids Contamination.Controlled..
Board of directors of Klenzaids Contamination Controls Private Limited (Klenzaids)
Klenzaids Contamination Controls Private Limited is the primary company behind Klenzaids. The board of Klenzaids Contamination Controls Private Limited currently have 5 directors; the longest-serving is Ramesh Parsram Lala, appointed in 1998. 12 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Ramesh Parsram Lala DIN 00270382 | Director | 22 Jan 1998 | 28 yrs 8 mo | Klenzaids Contamination Controls Private Limited |
| Hamish Chandru Shahani DIN 01255910 | Managing Director | 01 Dec 2006 | 19 yrs 10 mo | Klenzaids Contamination Controls Private Limited |
| Sreedhar Anehosur DIN 07178150 | Director | 08 Jun 2015 | 11 yrs 4 mo | Klenzaids Contamination Controls Private Limited |
| Stephan Thomas Maerz DIN 09018884 | Director | 13 Sep 2024 | 2 yrs 1 mo | Klenzaids Contamination Controls Private Limited |
| Krishnamurthy Hariharsubramanian DIN 01255960 | CFO | 16 Sep 2024 | 2 yrs 1 mo | Klenzaids Contamination Controls Private Limited |
People of Klenzaids
2 people are tracked at Klenzaids (1 in leadership, 1 in team); the tracked headcount is 382.
| Name | Role | Group |
|---|---|---|
| CEO | Leadership | |
Dipesh Pandey | Information Technology Officer | Team |
Complete people profiles for Klenzaids
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Klenzaids
Figures of Klenzaids Contamination Controls Private Limited, the primary company behind Klenzaids, for FY 2025. Revenue was ₹194 Cr (+13% year on year). Net profit was ₹22.14 Cr (11% margin). EBITDA was ₹32.43 Cr (17% margin). Revenue has grown at a compounded annual rate of +4% over three years and +13% over five years.
- ₹194 CrRevenue · FY 2025 · +13% YoY
- ₹22.14 CrNet profit · 11% margin
- ₹32.43 CrEBITDA · 17% margin
- ₹28.3 LakhPaid-up capital
- 382Employees (provident fund records)
- +4%Revenue CAGR, 3 years
- +13%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Klenzaids Contamination Controls Private Limited are on its company page.
Detailed financial statements for Klenzaids
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Top companies in Pharmaceuticals & Distribution
10 companies that operate in the same segment as Klenzaids (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 213.52 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Klenzaids
Klenzaids was founded in 1978.
Klenzaids is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Klenzaids has 382 employees.
The primary company behind Klenzaids, Klenzaids Contamination Controls Private Limited, reported revenue of ₹194 Cr for FY 2025, up 13% year on year.
Klenzaids is known for manufacturing Aseptic, Bioclean, and Containment equipment that are essential for plants in pharmaceutical, biological, life science, healthcare, electrical, space, and defense industries. Design and build services for turnkey labs and facilities are also provided to universities and public health establishments. As a joint venture member of Syntegon Technologies, a commitment to combating climate change is maintained. Contamination control practices have been refined over half a century through collaborations with various sectors to ensure products and environments are kept free from unintended elements, supporting global manufacturing norms across boundaries.
Klenzaids offers Aseptic Equipment and Design and Build Services.
Klenzaids operates through Klenzaids Contamination Controls Private Limited.
The legal entities of Klenzaids currently have 5 directors, including Hamish Chandru Shahani, Krishnamurthy Hariharsubramanian, Stephan Thomas Maerz and others.